Skip to content

Drug interactions

Hydrocodone + Larotrectinib

Severity: Minor

Hydrocodone and Larotrectinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Larotrectinib is a CYP3A4 substrate and has been described as a weak inhibitor of CYP3A4 in vitro, so a modest rise in hydrocodone levels is conceivable. Clinical significance is likely small and the evidence is largely theoretical.

What this interaction means in plain words

Hydrocodone and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Hydrocodone belongs to Musculoskeletal; Larotrectinib belongs to Oncology.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition by larotrectinib reducing hydrocodone clearance; not firmly established clinically.

What to do

Monitor for excess sedation or respiratory depression when starting larotrectinib in a patient taking hydrocodone. Adjust the opioid dose only if symptoms develop.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Hydrocodone and Larotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Hydrocodone with Larotrectinib?

MediHelp rates the interaction as minor. Hydrocodone and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Larotrectinib is a CYP3A4 substrate and has been described as a weak inhibitor of CYP3A4 in vitro, so a modest rise in hydrocodone levels is conceivable. Clinical significance is likely small and the evidence is largely theoretical.

How serious is the interaction between Hydrocodone and Larotrectinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for excess sedation or respiratory depression when starting larotrectinib in a patient taking hydrocodone. Adjust the opioid dose only if symptoms develop.

What other medicines interact with Hydrocodone?

MediHelp also lists interactions of Hydrocodone with, for example, Alvimopan, Bupropion-naltrexone, Isocarboxazid. The full list is on the Hydrocodone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in